ArticleEuropean radiology2026
Radiological risk factors for T2-T3 glottic carcinoma treated with (chemo)radiotherapy-a multicenter analysis.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesIn moderately advanced (T2-T3) glottic cancer, eligibility for organ-preserving surgery is limited by tumor extension into certain high-risk areas within the larynx that can be identified on preoperative imaging and serve as predictive factors for poorer outcomes. Their relevance in conservative treatment modalities, including (chemo)radiotherapy ([C]RT), remains unclear. The objective was to evaluate the impact of these predefined surgical high-risk zones in patients treated with (C)RT. MATERIALS AND
methodsThis retrospective study included patients with T2-3, N0-3, M0 glottic carcinoma treated with primary (C)RT and with available diagnostic imaging from three academic medical centers between 2014 and 2018. Imaging was scored for tumor involvement of high-risk areas. The 5-year rates of locoregional control (LRC) and disease-specific survival (DSS) were compared using the log-rank test and Cox proportional hazards model.
resultsImaging from 180 patients (mean age, 68 ± 11 years, 154 men) was assessed, with 173 entering the risk factor analysis after excluding unreliable scans. Significant findings were observed in the anterior larynx: vertical anterior commissure involvement negatively affected LRC and DSS, while horizontal anterior commissure and anterior paraglottic space reduced LRC. Deep vocal muscle infiltration showed negative trends. In multivariable analysis, vertical anterior commissure infiltration retained a trend toward lower DSS.
conclusionInvolvement of the anterior commissure, particularly vertical extension, which is a known predictive factor from surgical studies, likely predicts poorer outcomes after (C)RT for T2-T3 glottic carcinoma. Involvement of the anterior paraglottic space and depth of tumor infiltration carry potential predictive value. KEY POINTS: Question Can radiological risk factors proven in surgically treated patients with T2-T3 glottic carcinoma also predict treatment failure in patients treated with (chemo)radiotherapy? Findings On multivariable analysis, vertical anterior commissure involvement showed a trend toward poorer disease-specific survival. Clinical relevance Our findings contribute to the search for harmonized prognostic factors across treatment modalities for glottic carcinoma and provide a basis for integrating these risk factors into staging and treatment counseling.
Indexed as
Identifiers
42319407What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.